Skip to main content
Log in

Recommendations for the use bisphosphonates in patients with multiple myeloma (MM) have been updated by the American Society of Clinical Oncology

  • Guideline
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S, Orlowski RZ, Roodman DG, Twilde P, Anderson K.American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. Journal of Clinical Oncology 25: 2464-2472, No. 17, 10 Jun 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Recommendations for the use bisphosphonates in patients with multiple myeloma (MM) have been updated by the American Society of Clinical Oncology. Pharmacoecon. Outcomes News 531, 4 (2007). https://doi.org/10.2165/00151234-200705310-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705310-00007

Keywords

Navigation